Drugs / Foscelantan
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT06232421 | Nov 2025 → Apr 2026 overdue | chronic venous insufficiency | Research Institute for Physical Chemical Problems of the Belarusian State University | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Foscelantan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06232421 ↗ |